Download Free Sample Report

Newborn Screening for SMA and SCID Market, Global Outlook and Forecast 2024-2030

Newborn Screening for SMA and SCID Market, Global Outlook and Forecast 2024-2030

  • Published on : 26 June 2024
  • Pages :65
  • Report Code:SMR-7965217

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Newborn Screening for SMA and SCID market was valued at US$ 133 million in 2023 and is projected to reach US$ 276.3 million by 2030, at a CAGR of 11.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn?t otherwise apparent at birth.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID. This report contains market size and forecasts of Newborn Screening for SMA and SCID in global, including the following market information:

  • Global Newborn Screening for SMA and SCID Market Revenue, 2019-2024, 2025-2030, ($ millions)
  • Global top five companies in 2023 (%)

We surveyed the Newborn Screening for SMA and SCID companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newborn Screening for SMA and SCID Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Type, 2023 (%)

  • Instruments
  • Kits
  • Software

Global Newborn Screening for SMA and SCID Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, by Application, 2023 (%)

  • SCID Screening
  • SMA Screening

Global Newborn Screening for SMA and SCID Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Newborn Screening for SMA and SCID Market Segment Percentages, By Region and Country, 2023 (%)

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Newborn Screening for SMA and SCID revenues in global market, 2019-2024 (estimated), ($ millions)
  • Key companies Newborn Screening for SMA and SCID revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Perkinelmer
  • Thermo Fisher
  • ImmunoIVD
  • Labsystems Diagnostics

Outline of Major Chapters:
Chapter 1: Introduces the definition of Newborn Screening for SMA and SCID, market overview.
Chapter 2: Global Newborn Screening for SMA and SCID market size in revenue.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newborn Screening for SMA and SCID in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.